Form 4: UnitedHealth Group Director Kristen Gil Acquires Shares Through Dividend Equivalents
SEC Form 4 Filing
Director Kristen Gil of UnitedHealth Group acquired 4 shares of common stock through dividend equivalents, increasing her indirect holdings.
Summary
- Kristen Gil, a director at UnitedHealth Group, acquired 4 shares of common stock on December 17, 2024.
- These shares were obtained through dividend equivalents paid on vested deferred stock units.
- The dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units.
- Following the transaction, Ms. Gil's indirect holdings increased to 1,265 shares held by a trust.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively. The acquisition of shares through dividend equivalents is a standard practice and does not indicate any significant positive or negative sentiment.
Positives
- The acquisition of shares through dividend equivalents indicates a continued investment in the company by a director.
- The immediate vesting of the dividend equivalents aligns with the terms of the underlying deferred stock units.
Industry Context
This is a routine filing related to director compensation and is common in publicly traded companies. It reflects the ongoing process of equity-based compensation and dividend reinvestment.
Comparison to Industry Standards
- Many publicly traded companies use stock-based compensation, including dividend equivalents, as part of their executive and director compensation packages.
- The use of trusts to hold shares is a common practice for executives and directors for estate planning and tax purposes.
- The reporting of these transactions via SEC Form 4 is a standard regulatory requirement for insiders of public companies.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it reflects continued investment by a director.
- The transaction has no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 12/17/2024 | Date of the transaction where Kristen Gil acquired shares through dividend equivalents. |
| 12/19/2024 | Date the SEC Form 4 was signed by Faraz A. Choudhry, Attorney-in-Fact for Kristen L. Gil. |
Keywords
UnitedHealth Group, Director, Kristen Gil, Dividend Equivalents, Stock Acquisition, Deferred Stock Units, Beneficial Ownership, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.